Clinical Trial Update: Radiation Plus Cetuximab in Locally Advanced Non-Small Cell Lung Cancer (NSCLC) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating radiation plus cetuximab for locally advanced non-small cell lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Cetuximab (cetuximab)

Snippet

Sponsor: Heidelberg University | Conditions: Carcinoma, Non-Small-Cell Lung | Phase 2 | Status: COMPLETED